SOPHiA GENETICS
SOPH
32 hedge funds and large institutions have $86.3M invested in SOPHiA GENETICS in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 6 closing their positions.
10% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 10
6% more capital invested
Capital invested by funds: $81.4M → $86.3M (+$4.87M)
0.22% more ownership
Funds ownership: 26.59% → 26.81% (+0.22%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less funds holding
Funds holding: 36 → 32 (-4)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AKRE Capital Management
Middleburg,
Virginia
|
+$1.39M |
| 2 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$671K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$646K |
| 4 |
MSAM
Moloney Securities Asset Management
Manchester,
Missouri
|
+$453K |
| 5 |
LCM
Legato Capital Management
San Francisco,
California
|
+$262K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
-$1.34M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$386K |
| 3 |
Millennium Management
New York
|
-$324K |
| 4 |
Morgan Stanley
New York
|
-$220K |
| 5 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
-$140K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BCV
26
Banque Cantonale Vaudoise
Lausanne,
Switzerland
| $15K | -$28.5K | -5,900 | -66% |
|
27
AssetMark Inc
Concord,
California
| $9.27K | -$1.25K | -259 | -12% |
|
28
Wells Fargo
San Francisco,
California
| $3.45K | – | – | – |
|
29
Royal Bank of Canada
Toronto,
Ontario, Canada
| $3K | – | – | – |
|
|
NA
30
Nordwand Advisors
Radnor,
Pennsylvania
| $2.46K | -$7.24K | -1,500 | -75% |
|
|
PS
31
Principal Securities
Des Moines,
Iowa
| $463 | -$381 | -79 | -46% |
|
32
Russell Investments Group
London,
United Kingdom
| $256 | – | – | – |
|
|
PVI
33
Pura Vida Investments
New York
| – | -$1.34M | -284,724 | Closed |
|
|
PFM
34
Privium Fund Management
Amsterdam,
Netherlands
| – | -$140K | -29,080 | Closed |
|
35
Citadel Advisors
Miami,
Florida
| – | -$95K | -20,174 | Closed |
|
36
JP Morgan Chase
New York
| – | -$4.15K | -881 | Closed |
|
|
TRCT
37
Tower Research Capital (TRC)
New York
| – | -$3.15K | -669 | Closed |
|
38
Osaic Holdings
Scottsdale,
Arizona
| – | -$2.89K | -620 | Closed |
|
SOPH Hedge Fund Activity: Q1 2024 in Review
32 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in SOPHiA GENETICS (SOPH) for Q1 2024, worth a combined $86.3M — up 6% from $81.4M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of SOPH and 2 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 11 added.
The largest buyer was AKRE Capital Management, opening a new position worth an estimated $1.39M. The largest seller was Pura Vida Investments, exiting entirely with an estimated $1.34M sold.
- 32 institutional investors held SOPHiA GENETICS (SOPH) as of Q1 2024, down from 36 in Q4 2023.
- Funds reported $86.3M of SOPHiA GENETICS stock for Q1 2024, up 6% quarter-over-quarter.
- 2 funds opened new SOPHiA GENETICS positions in Q1 2024 and 6 closed out, a net change of -4 holders.
- The largest SOPHiA GENETICS buyer in Q1 2024 was AKRE Capital Management, an estimated $1.39M added.
- The largest SOPHiA GENETICS seller in Q1 2024 was Pura Vida Investments, an estimated $1.34M sold.
Based on aggregated 13F filings for Q1 2024.